ConductScience.org, home

Paper706

The effect of L-dopa on young patients with simple schizophrenia, treated with neuroleptic drugs: a double-blind cross-over trial with Madopar and placebo.

Gerlach J and 1 other. Psychopharmacologia, 1975. Cited by 93 papers, by iCite.

Cite this record

ConductScience Library. The effect of L-dopa on young patients with simple schizophrenia, treated with neuroleptic drugs: a double-blind cross-over trial with Madopar and placebo. Papers, record 706. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/706

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The effect of L-dopa on young patients with simple schizophrenia, treated with neuroleptic drugs: a double-blind cross-over trial with Madopar and placebo.
PubMed
Journal
Psychopharmacologia
PubMed
Year
1975
PubMed
Publication types
Clinical Trial, Controlled Clinical Trial, Journal Article
PubMed
Citations, by iCite
93
iCite
Relative citation ratio, by iCite
4.84
iCite
Revised in PubMed
2026-10-10
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gerlach JJ
2Lühdorf KK

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BenserazideMajor topic
HydrazinesMajor topic
LevodopaMajor topic
SchizophreniaMajor topic
Adult
Affect
Antipsychotic Agents
Anxiety
Basal Ganglia Diseases
Brief Psychiatric Rating Scale
Clinical Trials as Topic
Drug Combinations
Emotions
Humans
Placebos
Psychiatric Status Rating Scales
Schizophrenic Psychology
Social Behavior

Source PubMed

Download CSV of topics

References19

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14746324Effects of chronically administered L-dopa in normal and lesioned cats.J Pharmacol Exp Ther1973https://conductscience.org/library/papers/4746324PubMed
24707021Dopamine and noradrenaline receptor stimulation: reversal of reserpine-induced suppression of motor activity.Psychopharmacologia1973https://conductscience.org/library/papers/4707021PubMed
35491473On the role of brain catecholamines in motor activity: experiments with inhibitors of synthesis and of monoamine oxidase.Psychopharmacologia1970https://conductscience.org/library/papers/5491473PubMed
45171066Levodopa in the treatment of Parkinsonism.JAMA1971https://conductscience.org/library/papers/5171066PubMed
54608707A controlled study of the antipsychotic and sedative effects of neuroleptic drugs and amphetamine in chronic schizophrenics. A clinical and experimental-psychological study.Acta Psychiatr Scand Suppl1974https://conductscience.org/library/papers/4608707PubMed
64903690L-dopa therapy in Parkinson's disease: a critical review of nine years' experience.Can Med Assoc J1969https://conductscience.org/library/papers/4903690PubMed
74854165Role of noradrenaline in levodopa reversal of reserpine akinesia.Brain Res1974https://conductscience.org/library/papers/4854165PubMed
84988841The action of L-dopa on schizophrenic patients (a preliminary report).Curr Ther Res Clin Exp1970https://conductscience.org/library/papers/4988841PubMed
94471027Pharmacological vs. clinical physiognomy of neuroleptics, with special reference to their sedative and antipsychotic effects.Acta Psychiatr Belg1974https://conductscience.org/library/papers/4471027PubMed
104155234The clinical physiology of side effects in long-term L-DOPA therapy.Adv Neurol1974https://conductscience.org/library/papers/4155234PubMed
115000569Psychiatric side effects of levodopa in man.JAMA1971https://conductscience.org/library/papers/5000569PubMed
124147475An anatomy of schizophrenia?Arch Gen Psychiatry1973https://conductscience.org/library/papers/4147475PubMed
135335155Effects of L-DOPA on pharmacological parkinsonism.Acta Psychiatr Scand1966https://conductscience.org/library/papers/5335155PubMed
154266033Pathophysiology of schizophrenia and the striatum.Dis Nerv Syst1972https://conductscience.org/library/papers/4266033PubMed
165291459Mental complications of L-dopa therapy in Parkinson's patients.Isr Ann Psychiatr Relat Discip1971https://conductscience.org/library/papers/5291459PubMed
1713633822[Experimental neurological syndromes & psychiatric therapy. I. Neurological effects of a new important neuroleptic drug, RP 7843].Presse Med (1893)1959https://conductscience.org/library/papers/13633822PubMed
184648617Catecholamines and memory: enhanced verbal learning during L-DOPA administration.Psychopharmacologia1972https://conductscience.org/library/papers/4648617PubMed
195456717Psychosis and other psychiatric manifestations of levodopa therapy.Arch Neurol1970https://conductscience.org/library/papers/5456717PubMed
204578719Behavioral effects of L-dopa in schizophrenic patients.Psychopharmacologia1973https://conductscience.org/library/papers/4578719PubMed

Download CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 93 citations.

PMIDTitleJournalYearIn PapersSource
14668973A meta-analysis of the response to chronic L-dopa in patients with schizophrenia: therapeutic and heuristic implications.Psychopharmacology (Berl)2004https://conductscience.org/library/papers/14668973PubMed
8099795Cortical regulation of subcortical dopamine systems and its possible relevance to schizophrenia.J Neural Transm Gen Sect1993https://conductscience.org/library/papers/8099795PubMed
7862898Negative symptoms in schizophrenia: considerations for clinical trials. Working group on negative symptoms in schizophrenia.Psychopharmacology (Berl)1994https://conductscience.org/library/papers/7862898PubMed
6817367Partial improvement in negative schizophrenic symptoms after amphetamine.Psychopharmacology (Berl)1982https://conductscience.org/library/papers/6817367PubMed
6794086Vasopressin in anergic schizophrenia. A cross-over study with lysine-8-vasopressin and placebo.Psychopharmacology (Berl)1981https://conductscience.org/library/papers/6794086PubMed
2699936Depression in schizophrenia: current guidelines to treatment.Psychiatr Q1989https://conductscience.org/library/papers/2699936PubMed
2049366Negative symptoms: psychopathological models.J Psychiatry Neurosci1991https://conductscience.org/library/papers/2049366PubMed
34186Individual variations in the effects of flurazepam, clorazepate, L-dopa and thyrotropin-releasing hormone on REM sleep in man.Psychopharmacology (Berl)1979https://conductscience.org/library/papers/34186PubMed
14333Rehabilitation of the chronic schizophrenic patient: psychopharmacological aspects.Proc R Soc Med1976https://conductscience.org/library/papers/14333PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/706

GET https://conductscience.org/api/papers/v1/706/authors